A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Completed · Phase 1/Phase 2

Conditions studied: Seasonal Influenza

In brief

The purpose of this study is to measure the safety and the immune response to 3 next-generation influenza vaccine candidates (mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1) compared with influenza vaccine candidate mRNA-1010 controls in healthy adult participants.

Key facts

Study ID
NCT05827068
Run by
ModernaTX, Inc.
People needed
698
Starts
2023-03-27
Expected to finish
2023-11-20
Last updated by the study team
2025-02-03

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.